来自Hypericum Hookerianum的多环多烯酸酸葡萄和它们的免疫抑制活性
ZiFeng Guo1, WenJing Li1, ZhiKang Chen1
1Teaching and Research Department of Chinese Materia Medica Resources, College of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
Bioorganic chemistry
|October 30, 2025
概括
来自Hypericum hookerianum的9种新化合物,hyperhookeriones A-I,显示出免疫抑制的潜力. 化合物1通过阻断关键信号通路,有效地抑制T细胞的增殖.
科学领域:
- 自然产品化学 自然产品化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 超 (Hypericum hookerianum) 是一种生物活性化合物的植物来源.
- 多环多烯酸酸醇 (PPAP) 是一种具有多种生物活性的自然产品.
研究的目的:
- 从Hypericum hookerianum中分离和描述新的PPAP.
- 评估这些化合物的免疫抑制活性,并阐明它们的作用机制.
主要方法:
- 使用NMR,形状分析,量子计算和ECD光谱的植物化学研究.
- 在体外评估对T细胞增殖的免疫抑制活性.
- 涉及细胞因子抑制和信号通路分析的机制研究 (JAK3,STAT5,ERK1/2,AKT).
主要成果:
- 发现了9种新的PPAP,A-I型超克和11种已知的类似物.
- 化合物1表现出中度的免疫抑制活性 (IC50 = 16.51 ± 5.32 μM).
- 化合物1通过减少JAK3酸化来抑制促炎性细胞因子并阻止IL-2受体信号传递,从而导致细胞循环停止.
结论:
- 超 (Hypericum hookerianum) 是一种新型PPAP的丰富来源.
- 化合物1通过向T细胞激活通路,表现出显著的免疫抑制特性.
- 这些发现凸显了hyperhookeriones在管理免疫反应方面的治疗潜力.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
475
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
475
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
423
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
423


